Kirkland Advises KKR on Financing for Investment in Immedica Pharma
June 26, 2024
June 26, 2024
CHICAGO, Illinois, June 26 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis is advising KKR on the financing for its investment in Immedica Pharma, a Swedish pharmaceutical company focused on medicines for rare diseases and specialty care.
Immedica Pharma's existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside KKR. The transaction is subject to customary regulatory and cl . . .
Kirkland & Ellis is advising KKR on the financing for its investment in Immedica Pharma, a Swedish pharmaceutical company focused on medicines for rare diseases and specialty care.
Immedica Pharma's existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside KKR. The transaction is subject to customary regulatory and cl . . .